These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Application, to Japanese patients, of the 1982 American Rheumatism Association revised criteria for the classification of systemic lupus erythematosus. Yokohari R; Tsunematsu T Arthritis Rheum; 1985 Jun; 28(6):693-8. PubMed ID: 3873947 [TBL] [Abstract][Full Text] [Related]
24. Nail changes in connective tissue diseases: do nail changes provide clues for the diagnosis? Tunc SE; Ertam I; Pirildar T; Turk T; Ozturk M; Doganavsargil E J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):497-503. PubMed ID: 17373977 [TBL] [Abstract][Full Text] [Related]
25. Decreased nailfold capillary density in limited scleroderma with pulmonary hypertension. Ong YY; Nikoloutsopoulos T; Bond CP; Smith MD; Ahern MJ; Roberts-Thomson PJ Asian Pac J Allergy Immunol; 1998; 16(2-3):81-6. PubMed ID: 9876945 [TBL] [Abstract][Full Text] [Related]
26. Nailfold capillary microscopy in healthy children and in childhood rheumatic diseases: a prospective single blind observational study. Dolezalova P; Young SP; Bacon PA; Southwood TR Ann Rheum Dis; 2003 May; 62(5):444-9. PubMed ID: 12695158 [TBL] [Abstract][Full Text] [Related]
27. [Cross syndromes between systemic scleroderma and other connective tissue diseases]. Guseva NG; Akhnazarova VD Ter Arkh; 1974; 46(11):70-8. PubMed ID: 4439290 [No Abstract] [Full Text] [Related]
28. Elliptical broken line method for calculating capillary density in nailfold capillaroscopy: Proposal and evaluation. Karbalaie A; Abtahi F; Fatemi A; Etehadtavakol M; Emrani Z; Erlandsson BE Microvasc Res; 2017 Sep; 113():1-8. PubMed ID: 28414021 [TBL] [Abstract][Full Text] [Related]
29. Longitudinal nailfold capillaroscopy tracking of microangiopathic changes in systemic sclerosis. Dinsdale G; van Roon AM; Murray A; Taylor C; Herrick AL Rheumatology (Oxford); 2018 Sep; 57(9):1554. PubMed ID: 29506240 [No Abstract] [Full Text] [Related]
30. Association of anticardiolipin antibodies and abnormal nailfold capillaroscopy in patients with systemic lupus erythematosus. Bongard O; Bounameaux H; Miescher PA; De Moerloose P Lupus; 1995 Apr; 4(2):142-4. PubMed ID: 7795618 [TBL] [Abstract][Full Text] [Related]
31. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients. Payet J; Goulvestre C; Bialé L; Avouac J; Wipff J; Job-Deslandre C; Batteux F; Dougados M; Kahan A; Allanore Y J Rheumatol; 2014 Dec; 41(12):2395-402. PubMed ID: 25274898 [TBL] [Abstract][Full Text] [Related]
32. Predictive value of nailfold capillaroscopy in the diagnosis of connective tissue diseases. Blockmans D; Beyens G; Verhaeghe R Clin Rheumatol; 1996 Mar; 15(2):148-53. PubMed ID: 8777848 [TBL] [Abstract][Full Text] [Related]
33. Nailfold capillaroscopy and classification criteria for systemic sclerosis. Cutolo M; Matucci Cerinic M Clin Exp Rheumatol; 2007; 25(5):663-5. PubMed ID: 18078610 [No Abstract] [Full Text] [Related]
34. Clinical applicability of quantitative nailfold capillaroscopy in differential diagnosis of connective tissue diseases with Raynaud's phenomenon. Wu PC; Huang MN; Kuo YM; Hsieh SC; Yu CL J Formos Med Assoc; 2013 Aug; 112(8):482-8. PubMed ID: 24016612 [TBL] [Abstract][Full Text] [Related]
35. [Capillaroscopy and rheumatic diseases: state of the art]. Cutolo M; Sulli A; Secchi ME; Pizzorni C Z Rheumatol; 2006 Jul; 65(4):290-6. PubMed ID: 16823587 [TBL] [Abstract][Full Text] [Related]
36. [Morphological alterations in nailfold capillaroscopy and the clinical picture of vascular involvement in autoimmune diseases: systemic lupus erythematosus and type 1 diabetes]. Kuryliszyn-Moskal A; Ciołkiewicz M; Dubicki A Ann Acad Med Stetin; 2010; 56 Suppl 1():73-9. PubMed ID: 21365947 [TBL] [Abstract][Full Text] [Related]
37. [Nailfold capillaroscopy in dermatology]. Bahmer F Hautarzt; 1992 May; 43(5):314. PubMed ID: 1612923 [No Abstract] [Full Text] [Related]
38. [Rheumatic symptoms of scleroderma & lupus erythematosus]. NAVA P Bras Med; 1956 May 5-26; 70(18-21):232-4. PubMed ID: 13460129 [No Abstract] [Full Text] [Related]
39. [Apropos of "borderline" connective tissue diseases. Visceral lupus and scleroderma]. Cayla J; Saporta L; Delbarre F; Coste F Bull Mem Soc Med Hop Paris; 1967 Apr; 118(7):681-97. PubMed ID: 4170418 [No Abstract] [Full Text] [Related]